Gupta 2024 Figure 2 simple CP-AKI score after first IV cisplatin: age, hypertension, diabetes, current or former smoking, hemoglobin g/L, WBC, albumin g/L, magnesium mmol/L, and cisplatin dose mg. Max 22.5. Low / moderate / high / very_high. Not a diagnosis or chemo order. magent does not assay labs or dose cisplatin.

Runyon 1992 SAAG as serum albumin minus ascites albumin in g/dL, rounded to one decimal. portal_hypertension_physiology is true when SAAG >= 1.1 g/dL. Gradient only; not Light-style exudate/transudate criteria for ascites. Not a diagnosis. magent does not diagnose portal hypertension or peritonitis. Serum and ascites albumin as g/dL or g/L.

OPTN Policy 9 Table 9-1 PELD-Cr from age, albumin, bilirubin, INR, creatinine or dialysis/CVVHD, and caller-assigned minimum CDC height or weight Z-score. PELD = (sum of Table 9-1 terms + 1.5287) × 10 + 2.82; nearest integer; minimum 6. Albumin, bilirubin, and INR floor at 1.0; creatinine 1.3 mg/dL if >1.3 or dialysis/CVVHD. Not a transplant listing order. magent does not compute CDC LMS Z from height or weight.

Forrest 2005 Glasgow alcoholic hepatitis score from age, WBC, urea, PT ratio, and bilirubin (range 5-12) with the published ≥9 band. Deterministic published arithmetic with citation; not a steroid order.

NCI pack-year smoking exposure: pack_years = packs_per_day x years_smoked. One pack per day for one year is one pack-year; two packs per day for 0.5 year is the same. Provide packs_per_day (0-10) or cigarettes_per_day (0-200; 20 cigarettes = 1 pack), not both, plus years_smoked (0-80). magent does not take a smoking history interview. Not a lung-cancer screening order, COPD diagnosis, or medical device.

McDiarmid 2002 PELD from bilirubin, INR, albumin, age under 1 year, and growth failure. Deterministic published listing arithmetic with citation; not a transplant listing recommendation.

Alvarez 1999 revised original IAIHG AIH score, not Hennes 2008 simplified. Caller-assigned sex, ALP:AST/ALT ratio, globulin/IgG, ANA/SMA/LKM titer, AMA, viral markers, drugs, alcohol, additive histology, other autoimmune disease; optional HLA/other autoantibodies if seronegative and treatment response. Pretreatment definite >15 / probable 10-15; posttreatment definite >17 / probable 12-17. magent does not read histology. Not a diagnosis or immunosuppression order.

ARC-HBR (Urban 2019 Table 3). High bleeding risk at PCI iff ≥1 major or ≥2 minor. Binary; no weighted point score. Caller-assigned booleans; magent does not assay labs or read NIHSS. Mutex (400): severe vs moderate CKD, Hb <11 vs mild anemia, major vs minor bleed, moderate-severe stroke <6 mo vs any other ischemic stroke. Not a DAPT duration. Not a medical device.

Tavaglione 2023 fibrotic NASH index (FNI) from AST, HbA1c, and HDL cholesterol. FNI = e^x/(1+e^x) with x = -10.33 + 2.54*ln(AST) + 3.86*ln(HbA1c) - 1.66*ln(HDL mg/dL). HDL may be mg/dL or mmol/L (×38.67). Rule-out ≤0.10; indeterminate between 0.10 and 0.33; rule-in ≥0.33. Not a biopsy, not FIB-4, not the NAFLD fibrosis score, not SAFE, and not BARD.

Saltzman 2011 AIMS65 for in-hospital mortality in acute upper GI bleeding: albumin <3.0 g/dL, INR >1.5, caller-assigned altered mental status, systolic BP <=90 mm Hg, and age >65; 1 point each, max 5. Albumin 3.0, INR 1.5, and age 65 do not score; SBP 90 does. Score only; no mortality percentages. Not a diagnosis. Not Glasgow-Blatchford or Rockall. magent does not assess mental status. Albumin g/dL or g/L.

Oakland 2017 risk score for safe discharge after acute lower gastrointestinal bleeding. Points from age (0-2), sex (male 1), previous LGIB admission (1), caller-assigned blood on digital rectal examination (1), heart rate (0-3), systolic BP (0-5), and hemoglobin g/dL (0-22); max 35. safe_discharge when score ≤8 (derivation cutoff, not a later US validation). Not a discharge order or LGIB diagnosis. magent does not examine the rectum or assay hemoglobin. Hemoglobin g/dL or g/L.

Dominguez 2008 ABIC score from age, bilirubin, creatinine, and INR. ABIC = (age * 0.1) + (bilirubin_mg_dl * 0.08) + (creatinine_mg_dl * 0.3) + (inr * 0.8). Low <6.71, intermediate 6.71–9.0, high >9.0. Not a diagnosis of alcoholic hepatitis and not a steroid or transplant order.

Angulo 2007 NAFLD fibrosis score from age, BMI, IFG/diabetes, AST, ALT, platelets, and albumin. Deterministic published equation with citation. Not a biopsy or diagnosis. Not FIB-4, APRI, or BARD.

Barber 2011 United Kingdom end-stage liver disease (UKELD) from INR, creatinine, bilirubin, and sodium in native SI units. UKELD = 5.395*ln(INR) + 1.485*ln(creatinine_umol_l) + 3.13*ln(bilirubin_umol_l) - 81.565*ln(sodium_mmol_l) + 435, nearest integer. below_listing if <49; listing_threshold if ≥49 (UK elective-list 9% 1-year mortality cut). Not a transplant listing or allocation order. Not MELD or MELD-Na.

Bedogni 2006 fatty liver index from caller-supplied BMI, waist, triglycerides (mg/dL or mmol/L), and GGT. FLI = logistic(L)*100 with L from loge triglycerides, BMI, loge GGT, and waist. FLI <30 rules out hepatic steatosis; FLI >=60 rules in; 30 to <60 indeterminate. Not a diagnosis, imaging substitute, hepatic steatosis index, NAFLD fibrosis score, FIB-4, or APRI.

Lille model (Louvet 2007) from age, albumin, bilirubin at day 0 and day 7, creatinine, and PT seconds or INR. formula=pt or formula=inr is required; magent does not swap them. Score 0-1 with the published 0.45 cutoff. Deterministic published arithmetic with citation; not a medical device or a steroid order.

Daperno 2004 simplified endoscopic activity score for Crohn's disease (SES-CD): caller-assigned integers 0-3 for ulcers, ulcerated_surface, affected_surface, and narrowings in ileum, right_colon, transverse_colon, left_colon, and rectum (20 params). magent sums only (max 60). Unexamined segments are 0 as assigned by the caller. Daperno 2004 did not publish remission or response bands; magent returns score and max_score only. magent does not perform endoscopy. Not CDEIS and not Best 1976 CDAI.

Satsangi 2006 Montreal IBD phenotype (Vienna revision). Crohn: A1-A3, L1-L4, B1-B3, optional +L4 (not when isolated L4) and p. UC: E1-E3 plus S0-S3 as assigned. Compact string, no spaces. Not an activity index (not CDAI/Mayo), not Paris, not IBDU. magent does not perform endoscopy. Not a diagnosis. Not a medical device.

Glasgow-Blatchford score (Blatchford 2000) for need for treatment after upper-gastrointestinal haemorrhage. Points from urea, haemoglobin (sex-specific), systolic BP, heart rate ≥100, melena, syncope, hepatic disease, and cardiac failure; max 23. Score 0 is the published low-risk screen; magent does not invent other GBS bands. Not a diagnosis, not Rockall, and not AIMS65. Urea may be mmol/L or BUN mg/dL; haemoglobin g/L or g/dL.

Richards 1990 BUN/creatinine ratio as bun_mg_dl / creatinine_mg_dl, rounded to one decimal. A ratio of 36 or greater suggests upper gastrointestinal bleeding. A ratio below 36 is not helpful in locating the source and is not a lower-GI class. Provide creatinine_mg_dl (0.1-20) or creatinine_umol_l (9-1768), not both. Not a diagnosis, endoscopy order, or Blatchford urea band. magent does not locate a bleed.